Skip to main content

Table 1 Key characteristics of agents commonly used for sedation in intensive care unit (ICU) patients

From: 'Cooperative sedation': optimizing comfort while maximizing systemic and neurological function

Drug

Type of medication

Sedation

Analgesia

Mechanism of action

Advantages

Adverse effects

Fentanyl

Opioid

+

+++

Mu receptor agonist

Reversible, rapid onset, short duration

Respiratory depression, chest wall rigidity, gastric dysmotility, hypotension

Remifentanil

Opioid

+

+++

Mu receptor agonist

Reversible, rapid onset, short duration

Respiratory depression, chest wall rigidity, gastric dysmotility, hypotension

Morphine sulfate

Opioid

+

+++

Mu receptor agonist

Reversible

Respiratory depression, gastric dysmotility, hypotension, hallucinations

Diazepam

Benzodiazepine

+++

+

GABAa receptor agonist

Reversible

Respiratory depression, hypotension, confusion

Lorazepam

Benzodiazepine

+++

-

GABAa receptor agonist

Reversible

Respiratory depression, hypotension, confusion

Midazolam

Benzodiazepine

+++

-

GABAa receptor agonist

Reversible, shorter duration, and titratable

Respiratory depression, hypotension, confusion

Dexmedetomidine

Alpha-2 agonist

++

++

Alpha-2 receptor agonist (pre- and post-synaptic

Maintains cognitive function

Dry mouth, bradycardia, hypotension, adrenal suppression, atrial fibrillation

Propofol

 

+++

-

Unclear

Very short duration, easy to titrate

Hypotension, respiratory depression, metabolic acidosis, rhabdomyolysis, anaphylaxis, sepsis, pain at injection site